Bio-Rad Laboratories, Inc. Class B (NYSE: BIO.B) last traded at $365.08, up 0.00% on the session. The quote above updates while this page is open; the figures below are drawn from Bio-Rad Laboratories, Inc. Class B’s own filings and are restated only when a new one is published.
Bio-Rad Laboratories, Inc. Class B trades on NYSE under the ticker BIO.B. Its market capitalisation is $9.79 billion.
Valuation measures for Bio-Rad Laboratories, Inc. Class B, derived from the latest quote and its most recent SEC filing.
| Market cap | $9.79B |
|---|---|
| Enterprise value | $12.35B |
| P/E ratio | 44.58 |
| Price / sales | 3.78 |
| Price / book | 1.36 |
| Beta | 0.11 |
Trailing-twelve-month figures tagged in Bio-Rad Laboratories, Inc. Class B's XBRL filings with the SEC.
| Revenue (TTM) | $2.59B |
|---|---|
| Net income (TTM) | $222.40M |
| EPS (TTM) | $8.19 |
| Gross margin | 51.90% |
| Operating margin | 2.05% |
| Return on equity | 3.10% |
| Cash | $517.00M |
Range and volume for BIO.B over the past 52 weeks.
| 52-week high | $365.08 |
|---|---|
| 52-week low | $244.54 |
| Volume | 6 |
| Average volume | 225 |
| Previous close | $365.08 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.